Catastrophic antiphospholipid syndrome and Kikuchi-Fujimoto disease: The first case reported

Lupus

Volumn 14, Issue 12, 2005, Pages 967-969

  De Larrañaga, Gabriela F ^a,f   Remondino, G I ^b   Forastiero, R R ^c   Cunto, E R ^a   Narbaitz, M ^d   Olenchuk, A B ^e   Zala, N S ^a   San Juan, J A ^a  

^a Muñiz Hospital   (Argentina)

^b HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^c FAVALORO UNIVERSITY   (Argentina)

^d ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^e UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^f HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

Antiphospholipid antibodies; Catastrophic antibodies; Kikuchi Fujimoto; Malignant lymphoma; Recombinant human activated protein C; Systemic lupus erythematosus; Tuberculous limpadenitis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; DROTRECOGIN; HYDROCORTISONE; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; TUBERCULOSTATIC AGENT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; BLOOD CLOTTING; CASE REPORT; CYTOMEGALOVIRUS; DISEASE SEVERITY; FEVER; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIKUCHI DISEASE; LABORATORY TEST; LYMPHADENOPATHY; LYMPHOMA; MALE; MULTIPLE ORGAN FAILURE; NECROSIS; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERMINAL DISEASE; WEIGHT REDUCTION;

ADULT; ANTIPHOSPHOLIPID SYNDROME; HISTIOCYTIC NECROTIZING LYMPHADENITIS; HUMANS; MALE;

EID: 30644462163     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2232cr     Document Type: Article

References (12)

1. Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome. Where do we stand? Arthritis Rheum 2003; 48: 3320-3327.
2. Betrosian AP, Balla M, Papanikolaou M et al. Meningococcal purpura fulminans in a patient with systemic lupus erythematosus: a mimic for catastrophic antiphospholipid antibody syndrome? Am J Med Sci 2004; 327: 373-375.
3. Parappil A, Rifaath AA, Doi SAR, Pathan E, Surrum SK. Pyrexia of unknown origin: Kikuchi-Fujimoto disease. CID 2004; 39: 38-43.
4. Murga Sierra ML, Vegas E, Blanco-Gonzalez JE, Gonzalez A, Martinez P, Calero MA. Kikuchiùs disease with multisystemic involvement and adverse reaction to drugs. Pediatrics 1999; 104: e24.
5. Famularo G, Giustiniani MC, Marasco A, Minisola G, Nicotra GC, De Simone C. Kikuchi Fujimoto lymphadenitis: case report and literature review. Am J Hematol 2003; 74: 60-63.
6. Adhikari RC, Sayami G, Lee MC, Basnet RB, Shrestha PK, Shrestha HG. Kikuchi-Fujimoto diseases in Nepal. A study of 6 cases. Arch Pathol Lab Med 2003; 127: 1345-1348.
7. Asherson RA, Cervera R, Groot PG et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530-534.
8. Krueger GR, Huetter ML, Rojo J, Romero M, Cruz-Ortiz H. Human herpes viruses HHV-4 (EBV) and HHV-6 in Hodgkin's and Kikuchi's disease and their relation to proliferation and apoptosis. Anticancer Res 2001; 21: 2155-2161.
9. Quintás-Cardama A, Fraga M, Cozzi SN, Caparrini A, Maceiras F, Fortaleza J. Fatal Kikuchi-Fujimoto diseases: the lupus connection. Ann Hematol 2003; 82: 186-188.
10. Asherson RA, Cervera R. Antiphospholipid antibodies and infections. Ann Rheum Dis 2003; 62: 388-393.
11. Asherson RA, Cervera R, Piette JC et al. Catastrophic antiphospholipid syndrome. Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001; 80: 355-377.
12. Papaioannou G, Speletas M, Kaloutsi V, Pavlitou-Tsiontsi A. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease) associated with antiphospholipid syndrome: case report and literature review. Ann Hematol 2002; 81: 732-735.